Monday, June 01, 2020 1:19:02 PM
By pure coincidence, they also began lobbying the FDA to consider the hardships of poor little bio-startups whose trials happen to fail the PFS endpoint - yes, the same PFS that they themselves had set as the primary measurement component of the trial. Funny they would ask the FDA for that kind of leniency. Now why would they do that? Perhaps to help out potential competitors whose trials fail PFS? Now that would really be something, but, no, I don't think that's why. If you really think on it hard, you eventually stumble on the conclusion that they were probably asking the FDA for leniency because they know their own trial is a PFS failure.
Anyone with half a brain knows that if the trial had shown progress toward meeting the primary PFS endpoint, they would have ended the trial in 2015 and declared DCVax-L a great success. But they didn't. Instead, they went totally silent and tried to surreptitiously change the whole focus of the trial. It was at that point that this whole debacle became an outright scam because since that time all they have done is raise money to pay themselves $500,000 salaries, cut insider loan, warrant and real estate deals that have allowed them to pocket millions, dilute our stock with pump-and-dump schemes to pay off their buddies, and totally destroy the value of common shareholders' investments. And the whole time they've been laughing at you, daring you to do something about it. They lie with impunity and say things like we expect data lock to occur approximately by the end of May as a distraction while the reality is that behind the scenes all they were doing was preparing to unload another pump-and-dump payoff for their buddies. It's why they continue to miss financial reporting deadlines even after being rebuked by the SEC to clean up their act. Lying with impunity and incessant distractions are common characteristics of all scams.
Make no mistake. The evidence is overwhelming that this trial did fail. It is more than just a rumor.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM